TY  - BOOK
T1  - Examining the impact of voluntary restricted distribution systems in the pharmaceutical supply chain :hearing before the Subcommittee on Healthcare, Benefits, and Administrative Rules of the Committee on Oversight and Government Reform, House of Representatives, One Hundred Fifteenth Congress, first session, March 22, 2017.
CN  - Y 4.G 74/7:115-33
N1  - "Serial no. 115-33."
N1  - Shipping list no.: 2018-0099-M.
ID  - 1389097
KW  - Pharmaceutical industry
KW  - Pharmaceutical policy
KW  - Generic drugs
KW  - Prescription pricing
KW  - Competition
KW  - Consumer protection
KW  - Competition.
KW  - Consumer protection.
KW  - Pharmaceutical industry
KW  - Pharmaceutical policy.
KW  - Prescription pricing.
TI  - Examining the impact of voluntary restricted distribution systems in the pharmaceutical supply chain :hearing before the Subcommittee on Healthcare, Benefits, and Administrative Rules of the Committee on Oversight and Government Reform, House of Representatives, One Hundred Fifteenth Congress, first session, March 22, 2017.
LK  - http://purl.fdlp.gov/GPO/gpo86757
UR  - http://purl.fdlp.gov/GPO/gpo86757
ER  -